The global ulcerative colitis therapeutics market is valued at USD 7.2 billion in 2025. As per Fact.MR analysis, the industry will grow at a CAGR of 5.1% and will reach USD 11.9 billion by 2035. Ulcerative colitis, a type of chronic inflammatory bowel disease, causes acute inflammation and ulceration in the large bowel and rectum. In 2024, the therapeutics industry for ulcerative colitis saw significant growth fueled by the growing incidence of inflammatory bowel disease and the...